Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer

NCT01856855 is registered in ClinicalTrials.gov with John Fiveash, MD as lead sponsor.

NCT NCT01856855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01856855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Lead sponsor
John Fiveash, MD
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2013
Completion date
December 31, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, prostate cancer, radiation toxicity, sexual dysfunction